Skip to main content

Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area



Leishmania infantum and Dirofilaria immitis are among the most important canine vector-borne pathogens (CVBPs) of zoonotic concern in Europe. In endemic areas for both of these CVBPs, the use of systemic ectoparasiticides, such as afoxolaner (NexGard®; Boehringer Ingelheim Animal Health), may have the potential for controlling these infections. The aim of this study was to assess, for the first time, the insecticidal efficacy of NexGard® in decreasing the transmission of D. immitis and L. infantum to sheltered dogs living in a hyperendemic area, compared to the year before treatment, as well as its impact on the abundance of mosquito and sand fly populations.


All dogs (n = 179) enrolled in the study were divided into two groups based on their infection status at enrollment: a non-infected group (G1) and an infected group (G2; infected with D. immitis, L. infantum or both). The study was conducted from March 2020 to March 2021. In order to exclude all animals infected with L. infantum and D. immitis before March 2020 (sampling time: T0), dogs in G1 were sampled in June (T1; i.e. T0 + 90 days) and in October 2020 (T2; i.e. T0 + 210 days). From March to September 2020, all animals (G1 and G2) were weighed and treated monthly with NexGard®. Animals in G1 were tested for the last time in March 2021 (T3; i.e. T0 + 330 days) for assessing post-treatment incidence rate of infection and prevention efficacy.


The post-treatment incidence of D. immitis was 3.7% (1/27; 95% confidence interval [CI]: 0.2–18.1) and that of L. infantum was 3.6% (3/83; 95% CI: 1.0–10.1). Considering the annual incidence in 2019 and 2020, the protective efficacy against D. immitis and L. infantum infections was 94.2 and 64%, respectively. Of the female mosquitoes collected (n = 146), only one pool out of 50 tested positive for D. immitis DNA, whereas out of 1252 female Sergentomya minuta specimens collected, only four tested positive for L. infantum (0.3%).


Afoxolaner is efficacious in decreasing the rate of transmission of both D. immitis and L. infantum; however, comparison of the pre- and post-treatment period demonstrated that there was a significant difference only in the seasonal incidences of D. immitis infection. Preventive measures are recommended throughout the year in endemic areas to reduce the risk of pathogen transmission to animals and humans.

Graphical abstract


Leishmania infantum and Dirofilaria spp. are among the most important canine vector-borne pathogens (CVBPs) in Europe [1]. Leishmania infantum, a sand fly-transmitted protozoan, is the main causative agent of canine leishmaniosis (CanL) and of cutaneous and visceral leishmaniasis in humans [2]. The mosquito-transmitted nematode Dirofilaria immitis causes heartworm disease (HWD) in dogs and is also of zoonotic concern [1]. Dirofilaria immitis and L. infantum are widely distributed [1, 3], and the spread of these parasites is strictly related to the presence of infected dogs and vectors [3, 4]. Dirofilaria immitis infective stage larvae are transmitted by mosquito species of several genera (including Aedes, Anopheles and Culex) [5], whereas L. infantum infective promastigotes are vectored by phlebotomine sand fly species of the genus Phlebotomus in the Old World [3, 6]. Dogs living in areas of D. immitis and L. infantum endemicity are more susceptible to the infection during the activity season of their vectors, which is mostly related to the average seasonal temperature [7, 8].

In Italy, the epidemiology of both infections has been influenced by several factors, including vector distributions and chemoprophylactic treatments, which has over time resulted in a change in their original prevalence and distribution patterns throughout the country [9, 10]. An epidemiological survey conducted in a population of shelter dogs in Lecce province (Apulia region) revealed a high prevalence of D. immitis (53%) and L. infantum (58.1%) [11] and an annual incidence of 63.9 and 10%, respectively [11]. The circulation of D. immitis in this area has also been supported by the identification of two domestic cats infected with D. immitis and D. repens, respectively [12]. Given their high prevalence, the prevention of these parasitic infections is pivotal to reduce the high risk of infection in dogs, cats and humans [13, 14]. The current measures for L. infantum control, such as collars containing repellent insecticides, may be expanded by the use of isoxazoline systemic ectoparasiticides [15] by virtue of their insecticidal efficacy [16]. In a recent study, afoxolaner (Nexgard®; Boehringer Ingelheim Animal Health, Germany) has shown an insecticidal activity against Aedes aegypti [17] and Phlebotomus perniciosus [18]. It can therefore be hypothesized that regular monthly treatment of all dogs in a close environment could contribute to a decrease in the population of vectors and thus in the rate of pathogen transmission.

Taking all the data mentioned above into consideration, we conducted a field study to assess the decreased risk of L. infantum and D. immitis transmission based on treatment with afoxolaner (NexGard®) systemic insecticide on the vector population in a dog kennel where the vectors were collected, as well as the annual incidences of both CVBPs compared to the year before. In addition, the presence of Dirofilaria spp. and L. infantum was assessed in mosquito and sand fly populations trapped in the same enclosure.


Study design

The study was conducted from March 2020 to March 2021 in dogs living in a rescue shelter in the province of Lecce (40.419326°N, 18.165582°E; Apulian region, southern Italy) where CanL and HWD are highly endemic [11]. A total of 242 dogs living in the shelter were screened for entry into this non-controlled and non-blinded clinical field efficacy study. Animals were enrolled according to weight (≥ 2.0 kg), age (≥ 7 months old) and absence of major clinical conditions.

 Out of the 242 dogs living in the shelter, 179 were enrolled in the study and categorized based on their Dirofilaria spp. and L. infantum infection status. At enrollment (T0), blood sampling and clinical examination were conducted for each animal to establish the dog’s health status and to confirm the positivity or negativity to one or both infections. Due to the long pre-patent period of D. immitis infection, animals were further sampled at two time points, T1 (T0 + 90 days) and T2 (T0 + 210 days), in order to avoid positivity deriving from a previous infection (before March 2020). Subsequently, according to their infection status at T1, group 1 (G1) dogs were considered to be uninfected for Dirofilaria (G1-D) and/or Leishmania (G1-L), and group 2 (G2) dogs were considered to be infected by D. immitis and/or L. infantum (G2-D and G2-L, respectively) (Table 1). Thus, the animals in G2 were acting as continuous reservoirs for one or both pathogens. They were not subjected to any treatment against dirofilariosis or leishmaniosis except for medical necessity. The dogs did not receive any treatment with topical repellent insecticides, nor did they receive any heartworm preventative product.

Table 1 Number of dogs positive for Dirofilaria immitis and Leishmania infantum infections at three time points in 2020, prevalence of both infections in 2020 and number of new cases in March 2021

From March to September 2020, all enrolled dogs (G1 + G2) were treated once a month with the oral-systemic insecticide NexGard® (afoxolaner: 2.7–6.9 mg/kg). Treatments were administrated during the vector season at day 0, +30, +60, +90, +120, +150 and +180 (± 7 days). Dogs were weighed before each treatment to determine the appropriate dosage, in accordance with the label.

Efficacy assessment

The incidence for 2020 was calculated for dogs in G1 after the 2020 transmission season, during which they had been treated, and compared to that of the year before, during which there had been no treatment [19]. For this purpose, all dogs were tested at timepoints T1, T2 and T3 (T0 + 330 days).

The preventive efficacy of the monthly treatment was measured using this formula:

$$\begin{aligned} \% \,{\mkern 1mu} {\text{Decreased}}{\mkern 1mu} \,{\text{risk}}\,{\mkern 1mu} {\text{of}}\,{\mkern 1mu} {\text{transmission}} =\; & ({\text{incidence}}{\mkern 1mu} \,{\text{pre-treatment}} - {\text{incidence}}{\mkern 1mu} \,{\text{post-treatment}} \\ & /{\text{incidence}}{\mkern 1mu} \,{\text{pre-treatment}}) \times 100. \\ \end{aligned}$$

Dirofilaria immitis and L. infantum infections were studied separately; therefore, some dogs could be G1-D negative for Dirofilaria and G2-L positive for Leishmania, and vice versa. The analysis was performed with regard to G1-D and G1-L, corresponding to a treatment effect on different vectors, i.e. mosquitoes or sand flies.

Blood sampling and diagnostic procedures

Whole blood (5 ml) from each dog was collected in an EDTA tube (2.5 ml) and in a tube containing a clot activator (2.5 ml), respectively. An aliquot (1 ml) of whole blood was processed using a modified Knott’s test to morphologically identify and determine the number of circulating microfilariae (mfs), as previously described [11]. A second aliquot of blood (100 µl) was processed by duplex real-time PCR (qPCR) to detect and identify Dirofilaria spp. [20]. Dog serum samples were also tested for the detection of the D. immitis female antigen using a commercial immunochromatographic assay (SNAP® 4Dx Plus test; (IDEXX, Westbrook, ME, USA), according to the manufacturer’s instructions. Serum samples were also tested for anti-L. infantum antibodies with a slightly modified immunofluorescence antibody test (IFAT) protocol, as previously described [21].

Insect collections and infection rates

From May to November 2020, mosquito and sand fly specimens were collected in the dog shelter. Samplings were performed twice a month between 05:00 h and 08:00 h for both dipterans. Active adult mosquitoes were collected using two CO2-baited CDC light traps (Centers for Disease Control and Prevention, Atlanta, GA, USA), one gravid Aedes trap (GAT; BG-GAT; Biogents, Regensburg, Germany), one BG-sentinel-2 mosquito traps (Biogents) and one aspirator (InsectaVac Aspirator; BioQuip Products, Compton, CA, USA). Mosquito collections were carried out next to the dog cages or nearby stagnant water [22], and all captured mosquitoes were refrigerated until identification was made using morphological keys [23, 24]. Sand flies were collected using 64 sticky traps (white paper sheets coated with Castor oil [dimensions: 21.0 × 29.7 cm] covering a surface area of up to 4 m2) for each sampling and two CDC light traps [25]. Sand fly collections were carried out until their total disappearance (i.e. three consecutive negative collections). All specimens were stored in labeled glass vials containing 70% ethanol and then morphologically identified using taxonomic keys and descriptions [25, 26].

Pools of a maximum of ten specimens of mosquitoes or sand flies were tested by qPCR as described in section Molecular diagnosis. These pools were made based on specific criteria: species, site of the collection and collection date. The minimum infection rates (MIRs) were calculated using the standard formula for mosquito pools, as previously described [22]. The estimated rate of infection (ERI), which is adjusted for pooled samples, was calculated using the formula: ERI = 1 −  (1 − x/m)1/k, where x is the number of positive pools, m is the number of examined pools and k is the average number of specimens in each pool [27].

Molecular diagnosis

Genomic DNA was extracted from blood and/or mfs as well as from pools of sand flies and mosquitoes (i.e. abdomen and thorax samples) using the GenUP™ Blood DNA Kit (Biotechrabbit GmbH, Berline, Germany) and the phenol/chloroform extraction method followed by ethanol precipitation, respectively [11, 28, 29]. Heads and the last segments of phlebotomine sand flies were previously removed for morphological identification. All blood and mosquito DNA samples were tested by qPCR, using two species-specific primer sets targeting partial cytochrome oxidase subunit 1 (cox1) for D. immitis and the second internal transcribed spacer-2 (ITS-2) of nuclear ribosomal DNA for D. repens, as previously described [20]. All sand fly samples were tested by duplex real-time PCR (dqPCR) for the detection of Leishmania spp. as previously described [30]. Approximately 100 ng of gDNA (except for the no-template control) was added to each dqPCR run. All DNA samples were tested in duplicate, and positive and negative controls were included in each qPCR run.

Meteorological data

From May to November 2020, data on mean environmental temperature (°C), relative humidity (RH, %), monthly rainfall and wind speed were acquired from the climatological database of the “Agenzia Regionale per la Prevenzione e la Protezione dell’Ambiente” of Apulia Region. For the study site, relevant data from the nearest meteorological station were used for further analyses, such as correlating the meteorological data with the number of mosquitoes and sand flies caught each month.

Data and statistical analyses

Data on the incidence of dirofilariosis and leishmaniosis in dogs and mosquito/sand fly populations were recorded in an Excel (Microsoft Corp., Redmond, WA, USA) spreadsheet and analyzed by Quantitative Parasitology 3.0. software in the subsequent statistical analyses [31].

The criterion followed was the seroconversion or PCR positivity observed in subgroups G1-D and G1-L. The association between the category variables in the dog population (i.e. sex, age, weight, entrance date in the dog shelter), in mosquitoes and sand flies collected (i.e. number of female specimens for each mosquito and sand fly species) and the positive results to Dirofilaria spp. and L. infantum were analyzed using contingency tables and Pearson’s Chi-squared test (χ2) values were calculated. Results were considered statistically significant if P < 0.05.


The dogs in G1 which subsequently tested positive for L. infantum at T1 (n = 10) were considered to be infected before the sand fly season; therefore, the number of L. infantum-negative dogs (G1-L) in G1 was 83 (Table 1). The dogs in G1 which were subsequently diagnosed to be positive for D. immitis at T1 and T2 (n = 33) were considered to have been infected before the mosquito season, resulting in a total of 27 negative animals (G1-D) (Table 1). From group G1-D, in March 2021 (T3), one dog tested positive for D. immitis according to Knott’s test, the SNAP 4Dx Plus test and qPCR, indicating a single infection during the 2020 season. Therefore, the observed incidence was 3.7% (1/27; 95% confidence interval: 0.2–18.1) (Table 1). Compared to the previous year’s incidence of 63.9% (39/61 dogs infected) [19], the efficacy of the systemic insecticide in reducing the transmission of D. immitis by mosquitoes was 94.2%, with a statistically significant difference in incidence between the 2 years of (χ2 = 27.38, df = 1, P < 0.0001).

From group G1-L, in March 2021 (T3), three dogs tested positive for L. infantum, giving an incidence of 3.6% (3/83; 95% CI: 1.0–10.1) (Table 1). Compared to the previous year incidence of 10% (7/70 dogs seroconverted in 2019) [19], the treatment efficacy in reducing the transmission of L. infantum by sand flies was 64%; however, the difference was not statistically significant (χ2 = 2.72, df = 1, P = 0.098).

The mosquitoes collected during the whole sampling period (n = 219) belonged to three different genera and six species (Table 2). Of the females collected (n = 146), only 16 were engorged (7 Aedes albopictus, 4 Aedes caspius, 4 Culex pipiens and Culiseta annulata). Among all the mosquito species collected, C. pipiens was the most prevalent species (n = 97, 44.3%). In 2019, 208 females were collected during the same season period, a decrease of 29.8% [11]. The number of female mosquitoes collected for each species in 2019 is reported in Table 3. The mean number of mosquito specimens for each trap type was 1.5 for BG-sentinel 2 trap, 13.5 for CDC-light trap and 4.5 for the GAT.

Table 2 Number of female mosquito specimens and positive pools molecularly tested for Dirofilaria immitis along with the average number of mosquitoes per pool, minimal infection rate and percentage of estimated rate of infection
Table 3 Number of female mosquito specimens collected in 2019 in the dog shelter and positive pools molecularly tested for Dirofilaria immitis along with the average number of mosquitoes per pool, MIR and percentage of ERI

Out of 50 mosquito pools, one (containing three A. caspius females) tested positive for D. immitis DNA, with an overall MIR of 6.8/1000. The overall ERI (i.e. the probability of a single positive mosquito specimen) was 0.8%. The MIR and ERI for each species separately are reported in Table 2, as well as the number of specimens for each mosquito species. In 2019, four pools out of 38 were PCR positive for Dirofilaria, although the difference between the 2019 and 2020 mosquito collections was not statistically significant (χ2 = 2.93, df = 1, P = 0.087).

A total of 2306 phlebotomine sand flies (2138 Sergentomya minuta and 168 P. perniciosus) were collected, of which 1281 were females (1252 S. minuta and 29 P. perniciosus). Four S. minuta females tested positive for L. infantum (0.3%). The mean monthly meteorological values obtained for the area of the dog shelter were: 21.8 °C; 70.5% RH, mean rainfall of 0.02 mm and mean wind speed of 2.04 m/s.


The results of this study suggest that the monthly administration of afoxolaner (NexGard®) to sheltered dogs in an endemic area for dirofilariosis and leishmaniosis is efficacious in terms of decreasing the rate of transmission of both D. immitis and L. infantum. The seasonal incidence for D. immitis infection observed in 2019 (63.9%) and 2020 (3.7%) are significantly different. In order to avoid false negative dogs due to a hard diagnosis of D. immitis, for both incidence evaluations we employed several diagnostic tools, and the overall positivity was considered to be the final incidence 2019/2020 [32]. We adopted the classical 5% error threshold and found that no other comparisons were significant; nevertheless, with the multiple factors involved and the high variability, we may consider the risk of error alpha to be 10% (P = 0.1). In that case, Dirofilaria and Leishmania infection incidence values differ between the pre- and post-treatment periods, as do the number of mosquito pools that tested positive for D. immitis. The observed result is not due to any repellent effect of NexGard®, but most likely due to the insecticidal activity of afoxolaner contributing not only to a decrease in density of vectors but also to a reduction in the risk of infecting bites [17]. Both female mosquitoes and sand flies need a few days to digest their blood meal and lay eggs before a new meal [16]. During this period of 3–5 days, the majority of mosquitoes and sand flies that have bitten dogs treated with afoxolaner die [17, 18, 33].

Mosquito and sand fly females that feed on a treated and infected animal (G2) will not transmit any pathogens due to their death after the blood meal as well as to the longer developmental times required by Dirofilaria spp. and L. infantum inside the vector [26, 34]. Therefore, afoxolaner may reduce the subsequent transmission of Dirofilaria spp. and L. infantum since their development requires more days than the length of survival of the vector [14].

Under field conditions, only repellent pyrethroids (e.g. deltamethrin, flumethrin, permethrin) have been tested to assess their preventive efficacy against CVBDs (e.g. [35, 36]). The decreased risk of L. infantum transmission addressed by repellents, with formulations containing permethrin or flumethrin, in field studies is greater (from 88.9 to 100%) than that herein reported for CanL using systemic insecticides [37,38,39]. Since data on the prevention of HWD infection through a repellent or a systemic insecticide in field studies are not available in the literature, a comparison of their efficacy is not possible. To date, afoxolaner has been shown to be efficacious in preventing the transmission of Babesia canis [40], as an effect of the induced rapid mortality of its vector Dermacentor reticulatus and the longer transmission time of this protozoan (up to 72 h after tick attachment). In our study, the activity of afoxolaner for the prevention of CanL and HWD is not related to the time of transmission of Dirofilaria spp. or L. infantum (4–5 min), but to a vector killing effect between two consecutive bites [16, 41].

The low number of female mosquitoes collected (n = 146) represents a 30% decrease compared to the number collected the previous year (n = 208; Table 3); however, the limited sampling results prevent any definitive conclusions to be drawn on the abundance of female mosquitoes over the 2 years of the study. Accordingly, the overall MIR (6.8/1000) was lower than that recorded in 2019 (19.2/1000), with only one pool of A. caspius testing positive for D. immitis DNA. Moreover, the relative decrease in the number of A. caspius and relative increase in the number of C. pipiens collected compared to the year before could be due to the average temperature of the 2020 season being lower than that of the previous year [11], as well as to a potential different susceptibility of the two mosquito species to the insecticide used in the study. However, the impact of the insecticide on the density of the mosquito population should be further investigated. The higher occurrence of S. minuta, the sand fly species with herpetophilic attitude, than P. perniciosus, with mostly zoophilic behavior, could be related to the effect of afoxolaner treatment on the studied dog population. However, despite their different blood-feeding behaviors, four S. minuta tested positive for L. infantum, suggesting a putative role of this sand fly species in the transmission of this pathogen [42, 43] and a different susceptibility to afoxolaner compared to P. perniciosus [19, 44]. Both the above assumptions need to be further investigated.


The protection of dogs from infective bites of mosquito and sand fly vectors reduces their capacity to act as reservoirs of pathogens. Based on the One Health approach, dogs in endemic areas with a high risk of VBP exposure should be treated to decrease/prevent the risk of infection as well as the spread of these parasites to other animals and humans living in the same geographical area. Afoxolaner is efficacious in decreasing the rate of transmission of both D. immitis and L. infantum, although we found a significant difference between the 2 years of study only in the seasonal incidences of D. immitis infection. Our study is the first demonstration that systemic insecticides without repellent activity may play a role in decreasing the risk of pathogen transmission by mosquitoes and sand flies.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.



Canine vector-borne pathogens


Estimated rate of infection


Group 1


Group 2


Gravid Aedes trap


Heartworm disease


Immunofluorescence antibody test


Minimum infection rate


  1. Otranto D, Capelli G, Genchi C. Changing distribution patterns of canine vector-borne diseases in Italy: leishmaniosis vs. dirofilariosis. Parasites Vectors. 2009;2: S2.

    Article  Google Scholar 

  2. Dantas-Torres F. The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis. Vet parasitol. 2007;149:139–46.

    Article  Google Scholar 

  3. Dantas-Torres F, Solano-Gallego L, Baneth G, Ribeiro VM, de Paiva-Cavalcanti M, Otranto D. Canine leishmaniosis in the Old and New Worlds: unveiled similarities and differences. Trends Parasitol. 2012;28:531–8.

    Article  Google Scholar 

  4. Montoya-Alonso JA, Carretón E, Corbera JA, Juste MC, Mellado I, Morchón R, et al. Current prevalence of Dirofilaria immitis in dogs, cats and humans from the island of Gran Canaria, Spain. Vet Parasitol. 2011;176:291–4.

    Article  CAS  Google Scholar 

  5. Eldridge BF, Edman JD. Medical entomology. Dordrecht: Springer; 2000.

    Book  Google Scholar 

  6. Maroli M, Feliciangeli D, Bichaud L, Charrel RN, Gradoni L. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Med Vet Entomol. 2013;27:123–47.

    Article  CAS  Google Scholar 

  7. Genchi C, Rinaldi L, Mortarino M, Genchi M, Cringoli G. Climate and Dirofilaria infection in Europe. Vet Parasitol. 2009;163:286–92.

    Article  Google Scholar 

  8. Tarallo VD, Dantas-Torres F, Lia RP, Otranto D. Phlebotomine sand fly population dynamics in a leishmaniasis endemic peri-urban area in southern Italy. Acta Trop. 2010;116:227–34.

    Article  Google Scholar 

  9. Mendoza-Roldan J, Benelli G, Panarese R, Iatta R, Furlanello T, Beugnet F, et al. Leishmania infantum and Dirofilaria immitis infections in Italy, 2009–2019: changing distribution patterns. Parasites Vectors. 2020;13:193.

    Article  Google Scholar 

  10. Moirano G, Zanet S, Giorgi E, Battisti E, Falzoi S, Acquaotta F, et al. Integrating environmental, entomological, animal, and human data to model the Leishmania infantum transmission risk in a newly endemic area in northern Italy. One Health. 2020;10:100159.

    Article  CAS  Google Scholar 

  11. Panarese R, Iatta R, Latrofa MS, Zatelli A, Ćupina AI, Montarsi F, et al. Hyperendemic Dirofilaria immitis infection in a sheltered dog population: an expanding threat in the Mediterranean region. Int J Parasitol. 2020;50:555–9.

    Article  Google Scholar 

  12. Panarese R, Iatta R, Lia RP, Passantino G, Ciccarelli S, Gernone F, et al. Dirofilarioses in two cats in southern Italy. Parasitol Res. 2021.

    Article  PubMed  Google Scholar 

  13. Mirò G, Petersen C, Cardoso L, Bourdeau P, Baneth G, Solano-Gallego L, et al. Novel areas for prevention and control of canine leishmaniosis. Trends Parasitol. 2017;33:718–30.

    Article  Google Scholar 

  14. Otranto D, Dantas-Torres F, Mihalca AD, Traub RJ, Lappin M, Baneth G. Zoonotic parasites of sheltered and stray dogs in the era of the global economic and political crisis. Trends Parasitol. 2017;33:813–25.

    Article  Google Scholar 

  15. Gomez SA, Curdi JL, Hernandez JAC, Peris PP, Gil AE, Velasquez RVO, et al. Phlebotomine mortality effect of systemic insecticides administered to dogs. Parasites Vectors. 2018;11:230.

    Article  Google Scholar 

  16. Otranto D. Arthropod-borne pathogens of dogs and cats: from pathways and times of transmission to disease control. Vet Parasitol. 2018;251:68–77.

    Article  Google Scholar 

  17. Liebenberg J, Fourie J, Lebon W, Larsen D, Halos L, Beugnet F. Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard®. Évaluation de l’activité insecticide de l’afoxolaner contre Aedes aegypti chez les chiens traités avec NexGard. Parasite. 2017;24:39.

    Article  Google Scholar 

  18. Perier N, Lebon W, Meyer L, Lekouch N, Aouiche N, Beugnet F. Assessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogs. Parasite. 2019;26:63.

    Article  Google Scholar 

  19. Panarese R, Iatta R, Beugnet F, Otranto D. Incidence of Dirofilaria immitis and Leishmania infantum in sheltered dogs from southern Italy. Transbound Emerg Dis. 2021.

    Article  PubMed  Google Scholar 

  20. Latrofa MS, Montarsi F, Ciocchetta S, Annoscia G, Dantas-Torres F, Ravagnan S, et al. Molecular xenomonitoring of Dirofilaria immitis and Dirofilaria repens in mosquitoes from north-eastern Italy by real-time PCR coupled with melting curve analysis. Parasites Vectors. 2012;5:76.

    Article  Google Scholar 

  21. Otranto D, Paradies P, de Caprariis D, Stanneck D, Testini G, Grimm F, et al. Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic. Clin Vaccine Immunol. 2009;16:337–43.

    Article  CAS  Google Scholar 

  22. Ferreira CA, de Pinho MV, Novo MT, Calado MM, Gonçalves LA, Belo SM, et al. First molecular identification of mosquito vectors of Dirofilaria immitis in continental Portugal. Parasites Vectors. 2015;8:139.

    Article  Google Scholar 

  23. Severini F, Toma L, Di Luca M, Romi R. Le zanzare italiane: generalità e identificazione e gli adulti (Diptera, Culicidae). Fragmenta Entomol. 2009;41:213–372.

    Article  Google Scholar 

  24. Becker N, Petric D, Zgomba M, Boase C, Madon M, Dahl C, Kaiser A. Mosquitoes and their control. 2nd ed. Heidelberg: Springer; 2010.

    Book  Google Scholar 

  25. Dantas-Torres F, Tarallo VD, Otranto D. Morphological keys for the identification of Italian phlebotomine sand flies (Diptera: Psychodidae: Phlebotominae). Parasites Vectors. 2014;7:479.

    Article  Google Scholar 

  26. Killick-Kendrick R. Biology of Leishmania in phlebotomine sandflies. In: Lumsden WH, Evans DA, editors. Biology of the kinetoplastida. London: Academic Press; 1979. p. 395–460.

    Google Scholar 

  27. Cowling DW, Gardner IA, Johnson WO. Comparison of methods for estimation of individual-level prevalence based on pooled samples. Prev Vet Med. 1999;39:211–25.

    Article  CAS  Google Scholar 

  28. Sangioni LA, Horta MC, Vianna MCB, Gennari SM, Soares RM, Galvão MAM, et al. Rickettsial infection in animals and Brazilian spotted fever endemicity. Emerg Infect Dis. 2005;11:265–70.

    Article  Google Scholar 

  29. Latrofa MS, Angelou A, Giannelli A, Annoscia G, Ravagnan S, Dantas-Torres F, et al. Ticks and associated pathogens in dogs from Greece. Parasites Vectors. 2017;10:301.

    Article  Google Scholar 

  30. Latrofa MS, Mendoza-Roldan J, Manoj RS, Pombi M, Dantas-Torres F, Otranto D. A duplex real-time PCR assay for the detection and differentiation of Leishmania infantum and Leishmania tarentolae in vectors and potential reservoir hosts. Entomol Gen. 2021.

    Article  Google Scholar 

  31. Rozsa L, Reiczigel J, Majoros G. Quantifying parasites in samples of hosts. J Parasitol. 2000;86:228–32.

    Article  CAS  Google Scholar 

  32. Panarese R, Iatta R, Mendoza-Roldan JA, Szlosek D, Braff J, Liu J, et al. Comparison of diagnostic tools for the detection of Dirofilaria immitis infection in dogs. Pathogens. 2020;9:499.

    Article  Google Scholar 

  33. Otranto D, Dantas-Torres F, Fourie JJ, Lorusso V, Varloud M, Gradoni L, et al. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for studies evaluating the efficacy of parasiticides in reducing the risk of vector-borne pathogen transmission in dogs and cats. Vet Parasitol. 2021;290: 109369.

    Article  CAS  Google Scholar 

  34. Simón F, Siles-Lucas M, Morchón R, González-Miguel J, Mellado I, Carretón E, et al. Human and animal dirofilariasis: the emergence of a zoonotic mosaic. Clin Microbiol Rev. 2021;25:507–44.

    Article  Google Scholar 

  35. Otranto D, de Caprariis D, Lia RP, Tarallo V, Lorusso V, Testini G, et al. Prevention of endemic canine vector-borne diseases using imidacloprid 10% and permethrin 50% in young dogs: a longitudinal field study. Vet Parasitol. 2010;172:323–32.

    Article  CAS  Google Scholar 

  36. Tielemans E, Lebon W, Dumont P, Genchi M, Jeannin P, Larsen D. Efficacy of oral afoxolaner plus milbemycin oxime chewable (NexGard Spectra®, Merial) to prevent heartworm disease in dogs after inoculation with third stage larvae of Dirofilaria immitis. Presented at: 25th International Conference of the World Association for the Advancement of Veterinary Parasitology (WAAVP), 16–20 August 2015; Liverpool.

  37. Brianti E, Gaglio G, Napoli E, Falsone L, Prudente C, Basano FS, et al. Efficacy of a slow-release imidacloprid (10%)/flumethrin (4.5%) collar for the prevention of canine leishmaniosis. Parasites Vectors. 2014;7:327.

    Article  Google Scholar 

  38. Otranto D, Paradies P, Lia RP, Latrofa MS, Testini G, Cantacessi C, et al. Efficacy of a combination of 10% imidacloprid/50% permethrin for the prevention of leishmaniasis in kennelled dogs in an endemic area. Vet Parasitol. 2007;144:270–8.

    Article  CAS  Google Scholar 

  39. Papadopoulos E, Angelou A, Diakou A, Halos L, Beugnet F. Five-month serological monitoring to assess the effectiveness of permethrin/fipronil (Frontline Tri-Act®) spot-on in reducing the transmission of Leishmania infantum in dogs. Vet Parasitol Reg Stud Rep. 2020;7:48–53.

    Google Scholar 

  40. Beugnet F, Halos L, Larsen D, Labuschagné M, Erasmus H, Fourie J. The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs. Parasit Vectors. 2014;7:283.

    Article  Google Scholar 

  41. Bergman DK. Mouthparts and feeding mechanisms of haematophagous arthropods. In: Wikel SK, editor. The immunology of host-ectoparasitic arthropod relationships. Wallingford: CAB International; 1996. p. 38–45.

    Google Scholar 

  42. Pombi M, Giacomi A, Barlozzari G, Mendoza-Roldan J, Macrì G, Otranto D, et al. Molecular detection of Leishmania (Sauroleishmania) tarentolae in human blood and Leishmania (Leishmania) infantum in Sergentomyia minuta: unexpected host–parasite contacts. Med Vet Entomol. 2020;34:470–5.

    Article  CAS  Google Scholar 

  43. Latrofa MS, Iatta R, Dantas-Torres F, Annoscia G, Gabrielli S, Pombi M, et al. Detection of Leishmania infantum DNA in phlebotomine sand flies from an area where canine leishmaniosis is endemic in southern Italy. Vet Parasitol. 2018;253:39–42.

    Article  CAS  Google Scholar 

  44. Fossati FP, Maroli M. Laboratory tests of three repellents against Phlebotomus perniciosus (Diptera: Psychodidae). Trans R Soc Trop Med Hyg. 1986;80:771–3.

    Article  CAS  Google Scholar 

Download references


The authors are thankful to Viviana Domenica Tarallo (University of Bari, Italy) for providing the pictures of Leishmania infantum promastigotes and Dirofilaria immitis adults.


This work was supported by Boehringer Ingelheim Animal Health (France, Europe). The funders contributed to the data analyses and preparation of the manuscript.

Author information

Authors and Affiliations



RP, RI, DO and FB designed the study. RP, RI and DO conducted the field activities. RP and RI performed the laboratory analyses. RP and RI were responsible of data curation. FB performed the statistical analysis. RP wrote the first draft of the manuscript. RP, DO, RI, FB, DO, AZ and JAMR revised and edited the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Domenico Otranto.

Ethics declarations

Ethics approval and consent to participate

Animals were handled with regard for their well-being in compliance with the relevant BIAH Animal Care and Use/Ethics Committee approvals and were sampled following the approval of the Ethical Committee of the Department of Veterinary Medicine of the University of Bari, Italy (Prot. Uniba 12/20). The veterinarian responsible for all dogs located in the sheltered signed the informed consent before participating in the study.

Consent for publication

Not applicable.

Competing interests

FB is employed by the commercial company Boehringer Ingelheim Animal Health (France, Europe). The remaining authors have declared that no competing interests exist.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Panarese, R., Iatta, R., Mendoza-Roldan, J.A. et al. Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area. Parasites Vectors 14, 381 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: